Targeting of Interleukin-13 Receptor a2 for Treatment of Head and Neck Squamous Cell Carcinoma Induced by Conditional Deletion of TGF-ß and PTEN Signaling
|
Research Initiative
|
FDA
|
NIDCD, NIDCR
|
2010
|
|
Task Force on Environmental Health Risks and Safety Risks to Children: Coordinated Federal Action Plan to Reduce Racial and Ethnic Asthma Disparities
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG
|
NCMHD, NHLBI, NIAID, NICHD, NIEHS, NINR
|
2009
|
|
The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative
|
Research Initiative
|
FDA
|
NCCIH, NIA, NIBIB, NIDA, NIDCD, NIMH, NINDS
|
2014
|
|
The Critical Path Institute (C-Path) International Neonatal Consortia (INC)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
2015
|
|
The Critical Path Institute (C-Path) Global Pediatrics Trials Consortium
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
2015
|
|
The Effect of Various Drugs on the Retina
|
Other
|
FDA
|
NEI
|
2014
|
|
The Federal Tuberculosis Task Force
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, IHS, OS
|
NIAID, NICHD
|
1991
|
|
The Impact of Tobacco Use on Oral Health and the Oral Microbiome
|
Research Initiative
|
CDC, FDA
|
NCI
|
2012
|
|
The Interagency Committee on Human Nutrition Research (ICHNR)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIDDK
|
2013
|
|
The Intersection of Violence and HIV Risk in Women Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
OD/ DPCPSI/ OAR
|
2012
|
|
The Nanoscale Science, Engineering, and Technology (NSET) Subcommittee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIBIB, OD/ OSP
|
2001
|
|
The NIH Bone Marrow Stromal Cell Transplantation Center
|
Research Initiative
|
FDA
|
CC, NCI, NHLBI, NIAID, NIAMS, NIBIB, NIDCR, NINDS
|
2009
|
|
The Public Health Service (PHS) Men Who Have Sex With Men (MSM) Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NHLBI
|
2008
|
|
The Public Health Service (PHS) Review Committee on the Use of Marijuana in Clinical Research
|
Committee, Advisory Group, or Work Group
|
FDA, OS, SAMHSA
|
NCCIH, NIDA, NIMH, NINDS
|
2011
|
|
The Science of Sex and Gender in Human Health
|
Training Initiative
|
FDA
|
OD/ DPCPSI/ ORWH
|
2006
|
|
The U.S. Transfusion-Transmissible Infection Monitoring System (TTIMS) – Blood donation safety monitoring program
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NHLBI
|
2015
|
|
Therapeutics for Rare and Neglected Diseases (TRND)/FDA Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS
|
2009
|
|
Tobacco and Nicotine Research Interest Group (TANRIG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, SAMHSA
|
NCI, NHGRI, NHLBI, NIAAA, NIAID, NICHD, NIDA, NIEHS, NIMH, NINR, OD/ DPCPSI/ OBSSR
|
2003
|
|
Tobacco Regulatory Science Program (TRSP)
|
Research Initiative
|
FDA
|
CSR, NCI, NHLBI, NIAAA, NICHD, NIDA, NIDCR, NIEHS, OD/ DPCPSI/ ODP, OD/ OER
|
2012
|
|
Tox21 - Memorandum of Understanding on High Throughput Screening, Toxicity Pathway Profiling, and Biological Interpretation of Findings
|
Research Initiative
|
FDA
|
NCATS, NIEHS
|
2010
|
|
Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2009
|
|
Trans-NIH Plan for HIV-Related Research
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS
|
CSR, FIC, NCATS, NCCIH, NCI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ DPCPSI/ OAR, OD/ DPCPSI/ ORWH
|
1994
|
|
Treating for Two: Safe Medication Use in Pregnancy Initiative
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NICHD, OD/ DPCPSI/ ORWH
|
2012
|
|
Tularemia Animal Model Qualification Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2013
|
|
|